EPCAM and endometrial carcinoma: In the present study, RIP of EpCAM through EGF/EGFR signaling could neither be observed in an array of carcinoma cell lines nor be reproduced in RL95-2 endometrial carcinoma cells, independently of time points and EGF concentrations used (Fig 2).